Shingrix vaccine for people waiting for a kidney transplant
Treatments studied
Part of Infections, Kidney & urinary, Women’s health & pregnancy clinical trials.
This Phase 3 study tests whether the shingles vaccine Shingrix is safe and effective for adults with chronic kidney failure who are on the transplant waiting list. It aims to protect you from shingles while you may be dealing with transplant-related immune changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (age 18 to 70) and can sign consent
- You’re on a kidney transplant waiting list at a participating center (transplant expected in 3 to 24 months after your first Shingrix dose)
- You either can get Shingrix now per CDC timing, or you completed the Shingrix series 3 to 24 months ago
- You can safely receive or have already received the vaccine (and can follow pregnancy-prevention rules if you could become pregnant)
- You have no recent shingles, and you’re not allergic to Shingrix components
- You haven’t had certain recent infections/immune problems or other recent vaccines/experimental drugs that could interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new shingles vaccine for healthy adults 40 and older. It aims to see if the vaccine is safe and helps protect against shingles.
This Phase 2 study tests whether an additional Shingrix (RZV) vaccine dose helps prevent shingles in people who previously had an allogeneic bone marrow or stem cell transplant. It focuses on people who are at least a year out from their first two Shingrix doses.
This trial tests whether the shingles vaccine (RZV) is safe and works well for organ transplant recipients and their household members. It also includes people on dialysis or certain immunosuppressants.
This study tests whether an extra dose of the Shingrix shingles vaccine can boost protection in people who have had a solid-organ transplant. If you already received both doses of Shingrix after your transplant, this trial will give you an additional dose to see if it further strengthens your immune response.
This study tests whether an investigational shingles (herpes zoster) vaccine is safe and helps prevent shingles in children who have had a kidney transplant. Because these children take medicines to prevent rejection, the study specifically looks at vaccine effects in this higher-risk group.
This study tests the shingles vaccine in young adults who have had a solid organ transplant (like a kidney or liver) more than a year ago. The goal is to see if the vaccine works well and is safe for people on stable anti-rejection medicines.
Hear when a new Kidney Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.